IRIS - Res&Arch Institutional Research Information System - Research & Archive

CAMAIONI, Emidio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.930
EU - Europa 2.601
AS - Asia 559
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 6
OC - Oceania 2
Totale 6.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.921
UA - Ucraina 661
IE - Irlanda 610
IT - Italia 411
SE - Svezia 249
HK - Hong Kong 247
DE - Germania 164
FI - Finlandia 156
RU - Federazione Russa 121
VN - Vietnam 120
TR - Turchia 75
CN - Cina 72
GB - Regno Unito 48
FR - Francia 44
PL - Polonia 31
CH - Svizzera 24
BE - Belgio 23
NL - Olanda 15
SG - Singapore 15
GR - Grecia 12
RO - Romania 12
AT - Austria 11
EG - Egitto 7
IL - Israele 7
EU - Europa 6
LB - Libano 6
CZ - Repubblica Ceca 5
MX - Messico 5
UZ - Uzbekistan 5
CL - Cile 4
KR - Corea 4
SV - El Salvador 4
ID - Indonesia 3
BR - Brasile 2
JP - Giappone 2
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
IR - Iran 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
QA - Qatar 1
SA - Arabia Saudita 1
Totale 6.112
Salva come PNG Salva come JPEG
Città #
Dublin 606
Chandler 555
Jacksonville 408
San Mateo 336
Hong Kong 245
Altamura 165
Medford 156
Princeton 154
Dong Ket 119
Lawrence 105
Perugia 104
Wilmington 103
Ann Arbor 97
Andover 86
Izmir 74
Redmond 58
Des Moines 55
Saint Petersburg 49
Beijing 48
Boardman 32
Norwalk 23
Brussels 21
Helsinki 21
San Paolo di Civitate 21
Los Angeles 19
Woodbridge 18
Bucharest 11
Den Haag 11
Redwood City 11
Ashburn 10
Auburn Hills 10
New York 10
Rome 10
Falls Church 8
Milan 8
Cairo 7
San Diego 7
Shanghai 7
Lausanne 6
Mcallen 6
Ness Ziona 6
Renton 6
Simi Valley 6
Zhengzhou 6
Chicago 5
Florence 5
Frankfurt Am Main 5
Kraków 5
Singapore 5
Spoleto 5
Bologna 4
Centro 4
Fairfield 4
Gigante 4
Montefalco 4
Moscow 4
Seoul 4
Tappahannock 4
Winston-Salem 4
Cassino 3
Collazzone 3
Detroit 3
Fremont 3
Houston 3
Malang 3
Nanjing 3
San Giustino 3
Strasbourg 3
Terni 3
Città di Castello 2
Esslingen am Neckar 2
Fuzhou 2
La Canada Flintridge 2
Las Vegas 2
Mestrino 2
Misano Adriatico 2
Nea Smyrni 2
Radomsko 2
Shenzhen 2
Tübingen 2
Warsaw 2
Amsterdam 1
Auckland 1
Barcelona 1
Bastia umbra 1
Birmingham 1
Boydton 1
Brescia 1
Brno 1
Budapest 1
Buffalo 1
Böblingen 1
Cambridge 1
Camerino 1
Casoria 1
Clearwater 1
Copenhagen 1
Dallas 1
Dearborn 1
Denver 1
Totale 3.963
Salva come PNG Salva come JPEG
Nome #
Computational studies in enantioselective liquid chromatography: Forty years of evolution in docking- and molecular dynamics-based simulations 111
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 90
Structure-activity relationships of bisphophonate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists 81
Towards New Neuroprotective Agents: Design and Synthesis of Thieno[2,3-c]-isoquinolinon-5-one as a Potent PARP-1 Inhibitor. 77
Spiro[2.2]pentane as a Dissymmetric Scaffold for Conformationally Constrained Analogues of Glutamic Acid: Focus on Racemic 1-Aminospiro[2.2]pentyl-1,4-dicarboxylic Acids 74
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 73
Selective PARP-2 inhibitors increase apoptosis in hippocampal slices but protect cortical cells in models of post-ischaemic brain damage 72
Novel PARP Inhibitors: Synthesis and Molecular Modeling Studies 71
2-Substituted N-ethylcarboxamidoadenosine derivatives as high-affinity agonists at human A3 adenosine receptors 70
Metabotropic glutamate receptors: structure and new subtype-selective ligands 70
On the way to selective PARP-2 inhibitors. Design, synthesis, and preliminary evaluation of a series of isoquinolinone derivatives. 70
Spiro[2.2]pentane as a dyssymetric scaffold for conformationally constrained analogues of glutamic acid: diastereodivergent synthesis of 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 70
Design and synthesis of 4H-thieno[2,3-c]isoquinolin-5-one derivatives as potent PARP-1 inhibitors, on route of new antiischemic agents 69
Molecular recognition in P2 receptors: Ligand development aided by molecular modeling and mutagenesis 66
PARP inhibitors: polypharmacology versus selective inhibition 64
Binding Mode of 6ECDCA, a Potent Bile Acid Agonist of the Farnesoid X Receptor (FXR) 62
Adenosine receptor agonists: Synthesis and biological evaluation of the diastereoisomers of 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)NECA 61
Rat Brain Guanosine Binding Site:Biological Studies and Pseudo Receptor Construction 60
Preparation and use of nucleotide bisphosphate as P2Y antagonists 59
Targeting the FXR nuclear receptor through a virtual screening approach 59
3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.. 59
Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles. 58
Integrated Fragment-Based Approaches on the Route to Novel IDO1 Modulators 57
Effects of new arylazido compounds of pyridoxal phosphate on ecto-ATPase activity of guinea pig tissues 56
1μs Molecular Dynamics Simulations to study the poisoning effect of the PARP-1 full length enzyme 56
N-Decyl-S-trityl-(R)-cysteine, a new chiral selector for "green" ligand-exchange chromatography applications 56
Discovery and characterization of novel potent PARP-1 inhibitors endowed with neuroprotective properties: From TIQ-A to HYDAMTIQ 55
Dexpramipexole improves bioenergetics and outcome in experimental stroke 55
Adenosine Deaminase: Functional Implications and Different Classes of Inhibitors 54
Design, Molecular Modeling Studies, Synthesis and Preliminary Evaluation of Novel PARP-1 Inhibitors on the Road of Antiischemic Agents 54
2-Alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. 53
Modeling of Poly(ADP-ribose)polymerase (PARP) Inhibitors. Docking of Ligands and QSAR 52
Derived chromatographic indices as effective tools to study the self-aggregation process of bile acids 52
Chromatographic hydrophobicity index: a high-throughput tool to estimate the critical micellar concentration of bile acids 52
Chiral separation of helical chromenes with chloromethyl phenylcarbamate polysaccharide-based stationary phases 52
2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. 51
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy. 51
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. 50
Adenosine deaminase inhibitors: synthesis, diastereoisomeric resolution and biological activity of 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide. 49
6α-Ethyl-Chenodeoxycholic Acid (6-ECDCA), a Potent and Selective FXR Agonist Endowed with Anticholestatic Activity 49
6a-Ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity. 48
8-Bromo-9-etiladenine come tools per l’ottenimento di antagonisti selettivi per il recettore adenosinico A2B 48
Compendio teorico-pratico di analisi farmaceutica. Riconoscimento delle sostanze solide iscritte nelle vigenti farmacopee 48
Adenosine deaminase inhibitors: Structure-activity relationships in 1-deazaadenosine and erythro-9-(2-hydroxy-3-nonyl)adenine analogues 48
The relationship between s. Aureus and branched-chain amino acids content in composite cow milk 48
New Insights from Crystallographic Data: Diversity of Structural Motifs and Molecular Recognition Properties between Groups of IDO1 Structures 48
BF3·Et2O-Promoted Decomposition of Cyclic α-Diazo-β-Hydroxy Ketones: Novel Insights into Mechanistic Aspects 48
Molecular docking and spatial coarse graining simulations as tools to investigate substrate recognition, enhancer binding and conformational transitions in indoleamine-2,3-dioxygenase (IDO). 47
Highlights at the gate of tryptophan catabolism: a review on the mechanism of activation and regulation of indoleamine 2,3-dioxigenase (IDO), a novel target in cancer disease 46
Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites 46
Chiral ligand-exchange separation and resolution of extremely rigid glutamate analogues: 1-aminospiro[2.2]pentyl-1,4-dicarboxylic acids 45
The Janus-faced nature of IDO1 in infectious diseases: Challenges and therapeutic opportunities 45
Synthesis and Biological Evaluation of 2-(3’-(1H-tetrazol-5-yl)bicyclo[1.1.1]pent-1-yl)glycine (S-TBPG), a novel mGlu1 Receptor 44
Chiral ligand-exchange separation and resolution ofextremely rigid glutamate analogs: 1-aminospiro[2.2]pentyl-1,4-dicarboxylicacids. 44
Bile acids: property-activity relationship and molecular modelling studies 43
Targeting Wnt-driven cancers: Discovery of novel tankyrase inhibitors 43
Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis 43
Molecular determinats for metabotropic glutamate receptor activation and blockade. Molecular dynamics and electrostatic potential analysis studies 42
Studies on the interaction between PARP’s catalytic site and inhibitors. Design and synthesis of new class of inhibitor derivatives 42
On the Way to Selective PARP-2 Inhibitors: Design, Synthesis and Preliminary Evaluation of a Series of Isoquinolinone Derivatives 42
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. 42
Fragment based drug design and diversity-oriented synthesis of carboxylic acid isosteres 42
Stereoselective Synthesis and Preliminary Evaluation of (+)- and (-)-3-methyl-5-carboxy-thien-2-yl-glycine (3-MATIDA): Identification of (+)-3-MATIDA as a Novel mGluR1 Competitive Antagonist 41
Dominant Factors Affecting the Chromatographic Behaviour of Bile Acids 41
Fast chromatographic determination of the bile salt critical micellar concentration 41
Pharmacology of the highly selective A1 adenosine receptor agonist2-chloro-N6-cyclopentyladenosine. 41
Inhibitory Effects of 1-Deazaadenosine Analogues on HIV Replication and Adenosine Deaminase 41
Studies guanosine binding sites in rat brain: S.A.R. analysis and pharmacophore design 40
Synthesis, molecular modelling and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO) 40
Rat brain guanosine binding site. Biological studies and pseudo-Receptor construction 39
Design, Synthesis, Crystallographic Studies and Preliminary Biological Appraisal of New Substituted Triazolo[4,3-b]pyridazin-8-amine Derivatives as Tankyrase Inhibitors. 39
Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors 39
Hydrophobic Amino Acid Content in Onions as Potential Fingerprints of Geographical Origin: The Case of Rossa da Inverno sel. Rojo Duro 39
Enantioselective HPLC analysis to assist the chemical exploration of chiral imidazolines 39
Use of RP-HPLC on a Dynamically Coated Artificial Membrane to Predict Intestinal Absorption of Bile Acids 38
Xaa-prolyl dipeptidyl aminopeptidase may play an important role in biofilm formation by Streptococcus mutans 38
Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure Activity Relationship of a Series of Body and Side Chain Modified Analogs of Chenodeoxycholic Acid 38
Branched-chain amino acids as potential diagnostic and prognostic disease biomarkers 38
HYDAMTIQ: A New, Potent PARP-1 Inhibitor with Neuroprotective Properties 37
Synthesis and Receptor Affinity of Polysubstituted Adenosines 37
Synthesis of New Nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 37
Insights in the PARP1 poisoning effect 37
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin 36
Synthesis, enantiomeric separation and preliminary evaluation of a series of new thioidantoine derivatives as inhibitors of indoleamine-2,3-dioxygenase (IDO), a novel target for cancer therapy 36
The relationships between somatic cells and isoleucine, leucine and tyrosine content in cow milk 36
Characterization of potent ligands at human recombinant adenosine receptors 36
Synthesis and biological activity of 3'-deoxy derivative of adenosine (5'-N-methylcarboxamide) (MECA) 35
New insights into the evaluation of the bile salt critical micellar concentration 35
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls 35
Heterocycles as companions on route to drug discovery 34
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 34
Investigating the allosteric reverse signalling of PARP inhibitors with microsecond molecular dynamic simulations and fluorescence anisotropy 34
Therapeutic Potential of a Novel Poly(ADP-ribose) Polymerase Inhibitor, Hydamtiq, in Human Pancreatic and Colon Cancers 34
Life or Death Decisions. The case of Poly(ADP-Ribose)Polymerase (PARP) as therapeutic target for brain ischemia 33
Fast chromatographic determination of the unconjugated bile salt critical micellar concentration 33
High-throughput chromatographic determination of the bile acid critical micellar concentration 33
RP-18-BASE-DEACTIVATED, una nuova fase stazionaria per l’analisi cromatografica degli acidi biliari 33
Synthesis and biological evaluation of N6-cycloalkyl derivatives of1-deazaadenine nucleosides: a new class of anti-human immunodeficiency virus agents. 33
Synthesis of 2′-Deoxyribonucleoside Derivatives of 1-Deazapurine 33
Heterocycles as Companions on Route to Drug Discovery 33
Totale 4.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.952
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.952
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 0 85 3
2019/2020578 7 11 100 2 107 7 107 7 109 70 19 32
2020/20211.330 3 107 31 100 405 69 121 29 169 32 119 145
2021/20221.214 33 212 11 54 37 11 13 405 43 51 138 206
2022/20232.058 165 391 30 121 178 215 3 83 760 7 76 29
2023/2024575 47 104 44 12 7 15 182 29 88 28 19 0
Totale 6.490